7.0 - 107.5 TCD50/ml, 78.0-83.0; 6% solution of aluminum hydroxide gel, the balance. Vaccine enhances accumulation of specific protective antibodies in serum blood of vaccinated animals and provides the development of immunity against infectious keratoconjunctivitis that is retained for one year.;EFFECT: enhanced effectiveness and valuable properties of vaccine.;4 tbl, 6 ex"/>
公开/公告号RU2264227C1
专利类型
公开/公告日2005-11-20
原文格式PDF
申请/专利权人
申请/专利号RU20040105105
申请日2004-02-24
分类号A61K39/295;C12N1/20;C12N7/00;A61P31/00;
国家 RU
入库时间 2022-08-21 21:21:51